日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia

对既往接受过治疗的华氏巨球蛋白血症患者进行维奈托克单药治疗的长期随访

Castillo, Jorge J; Guijosa, Alberto; Allan, John N; Siddiqi, Tanya; Advani, Ranjana H; Flynn, Catherine A; Meid, Kirsten; Budano, Nina; Nguyen, Julia; Ramirez-Gamero, Andres; Tsakmaklis, Nicholas; Hunter, Zachary R; Patterson, Christopher J; Treon, Steven P; Sarosiek, Shayna

Immunological memory to COVID-19 vaccines in immunocompromised and immunocompetent children

免疫功能低下和免疫功能正常的儿童对新冠疫苗的免疫记忆

Russo, Constanza; Otero, Adrián; Uranga, Macarena; Seery, Vanesa; Raiden, Silvina; Algieri, Silvia; De Carli, Norberto; Borda, Mauricio; Albistur, María F; Heinitz, Lourdes; Marcó Del Pont, María; Pardini, Martina; Budano, Guillermina; Alvarez, Laura; Simaz, Nancy; Merhar, Claudia; Quintana, María C; Garbini, Cecilia; Portela, Luisa Aedo; Pereira, Misael Salcedo; Ferrero, Fernando; Geffner, Jorge; Arruvito, Lourdes

A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer

TRAILR2/CDH3 双特异性抗体在 CDH3 阳性胰腺癌中表现出选择性凋亡和肿瘤消退

Peter Jung, Stefan P Glaser, Jing Han, Alexandra Popa, Laura Pisarsky, Ningping Feng, Antonia Geyer, Franziska Haderk, Donat Alpar, Christopher Bristow, Susanne Schmittner, Paula-Elena Traexler, Mikhila Mahendra, Birgit Poehn, Poojabahen Gandhi, Roberto Fiorelli, Sanket Awate, Nicole Budano, Florian

Precision RNAi using synthetic shRNAmir target sites

使用合成 shRNAmir 靶位进行精准 RNAi

Thomas Hoffmann #, Alexandra Hörmann #, Maja Corcokovic #, Jakub Zmajkovic, Matthias Hinterndorfer, Jasko Salkanovic, Fiona Spreitzer, Anna Köferle, Katrin Gitschtaler, Alexandra Popa, Sarah Oberndorfer, Florian Andersch, Markus Schaefer, Michaela Fellner, Nicole Budano, Jan G Ruppert, Paolo Chetta,

Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition

BI 836880(一种双重血管内皮生长因子和血管生成素 2 抑制剂)单独使用和与程序性细胞死亡蛋白 1 抑制剂联合使用时的药效学和抗肿瘤活性

Irmgard Hofmann, Anke Baum, Marco H Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg, Klaus-Peter Künkele

Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma

单细胞分析揭示代谢重编程是 BRAF 突变多发性骨髓瘤的耐药机制

Johannes M Waldschmidt, Jake A Kloeber, Praveen Anand, Julia Frede, Antonis Kokkalis, Valeriya Dimitrova, Sayalee Potdar, Monica S Nair, Tushara Vijaykumar, Nam Gyu Im, Amy Guillaumet-Adkins, Nitish Chopra, Hannah Stuart, Lillian Budano, Noori Sotudeh, Guangwu Guo, Clemens Grassberger, Andrew J Yee,

In memoriam Emil Płowiecki

谨此缅怀埃米尔·普沃维茨基

Ballocca, Flavia; D'Ascenzo, Fabrizio; Moretti, Claudio; Diletti, Roberto; Budano, Carlo; Palazzuoli, Alberto; Reed, Matthew J; Palmerini, Tullio; Dudek, Dariusz; Galassi, Alfredo; Omedè, Pierluigi; Mieghem, Nicolas M; Ferenbach, David; Pavani, Marco; Della Riva, Diego; Mills, Nick L; Van Domburgh, Ron T; Mariani, Andrea; Dziewierz, Artur; di Cuia, Marco; Jan van Geuns, Robert; Zijlstra, Felix; Bergerone, Serena; Marra, Sebastiano; Biondi Zoccai, Giuseppe; Gaita, Fiorenzo; Team, Editorial; García, Luis Antonio Íñigo

Sometimes neither water nor fire are more useful than friendship-a new risk score for prediction of contrast-induced nephropathy (CIN) and long-term adverse outcomes in patients undergoing coronary angiography

有时,友谊比水火都更有用——一种用于预测冠状动脉造影患者造影剂肾病 (CIN) 和长期不良预后的新风险评分

De Filippo, Ovidio; D'Ascenzo, Fabrizio; Piroli, Francesco; Budano, Carlo; De Ferrari, Gaetano Maria